[HTML][HTML] Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
B Neuber, M Schmitt - Biotarget, 2019 - biotarget.amegroups.org
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising
approach in tumor immunotherapy - Neuber - Biotarget Have a website account?Log In orRegister …
approach in tumor immunotherapy - Neuber - Biotarget Have a website account?Log In orRegister …
[PDF][PDF] Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
B Neuber, M Schmitt - 2019 - pdfs.semanticscholar.org
B-cell neoplasia, including acute lymphoblastic leukemia and non-Hodgkin's lymphoma (3).
In particular, trials with the transfer of autologous CD19-CAR T cells in patient with …
In particular, trials with the transfer of autologous CD19-CAR T cells in patient with …
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
B Neuber, M Schmitt - Biotarget, 2019 - biotarget.amegroups.org
Cell gene therapy is a promising approach for the treatment of cancers resistant to
conventional therapy with cytostatic drugs and monoclonal antibodies. In particular, the use …
conventional therapy with cytostatic drugs and monoclonal antibodies. In particular, the use …
[PDF][PDF] Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
B Neuber, M Schmitt - 2019 - cdn.amegroups.cn
B-cell neoplasia, including acute lymphoblastic leukemia and non-Hodgkin's lymphoma (3).
In particular, trials with the transfer of autologous CD19-CAR T cells in patient with …
In particular, trials with the transfer of autologous CD19-CAR T cells in patient with …